Skip to main content
Premium Trial:

Request an Annual Quote

Arcis, Opentrons Sign Sample Prep Product Distribution Deal

NEW YORK — Arcis Biotechnology said today that it has signed a global distribution agreement for its nucleic acid sample prep products with Opentrons.

Under the terms of the deal, New York City-based Opentrons will offer Arcis' line of nucleic acid extraction and preservation products with its automated OT-2 lab robot platform to customers worldwide. Additional terms were not disclosed.

"Arcis' reagent-only solution is a compelling offering for biologists, but when you automate that protocol, it offers a high-throughput sample preparation workflow for every molecular biology laboratory," Opentrons Cofounder and Chief Product Officer Will Canine said in a statement.

Earlier this year, UK-based Arcis inked a comarketing deal for its sample prep reagents with Andrew Alliance. In late 2018, it signed an agreement giving Teleflex the right to use the chemistry to develop a diagnostic assay.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.